Characterization of the germline and somatic mutation profile in familial pancreatic cancer reveals pathogenic germline variants and potentially druggable somatic mutations.

Autor: Earl, J., Castillo, M., Barreto, E., Rodríguez-Garrote, M., Pachón, V., Ferreiro, R., Villamayor, M., Malats, N., Muñoz, G., Carrato, A.
Zdroj: In Pancreatology November 2020 20 Supplement 1:S108-S108
Databáze: ScienceDirect